Inventor · disambiguated record
Kadum A. Al Shareffi
Also filed as: AL SHAREFFI KADUM A
8 granted patents·3 pending applications·35 citations·filing 2008–2019
86Inventor score
Top patents by PatentIndex Score
11 records- 0189US9314461B2Oral formulations and lipophilic salts of methylnaltrexoneWYETH LLC·Filed 2013·Granted Apr 19, 2016·9 cites·40 claims
- 0289US8524276B2Oral formulations and lipophilic salts of methylnaltrexoneSHAH SYED M·Filed 2011·Granted Sep 3, 2013·11 cites·27 claims
- 0387US8956651B2Oral formulations and lipophilic salts of methylnal trexoneWYETH LLC·Filed 2013·Granted Feb 17, 2015·6 cites·31 claims
- 0484US10307417B2Oral formulations and lipophilic salts of methylnaltrexoneWYETH LLC·Filed 2018·Granted Jun 4, 2019·2 cites·29 claims
- 0581US9102680B2Crystal forms of (R)-N-methylnaltrexone bromide and uses thereofPROGENICS PHARM INC·Filed 2012·Granted Aug 11, 2015·4 cites·14 claims
- 0680US10507206B2Oral formulations and lipophilic salts of methylnaltrexoneWYETH LLC·Filed 2019·Granted Dec 17, 2019·1 cites·25 claims
- 0779US10376505B2Oral formulations and lipophilic salts of methylnaltrexoneWYETH LLC·Filed 2018·Granted Aug 13, 2019·1 cites·30 claims
- 0877US2020121673A1Oral formulations and lipophilic salts of methylnaltrexoneWYETH LLC·Filed 2019·Application pending·0 cites
- 0972US9879024B2Crystal forms of (R)-N-methylnaltrexone bromide and uses thereofPROGENICS PHARM INC·Filed 2015·Granted Jan 30, 2018·1 cites·30 claims
- 1060US2010305323A1Crystal forms of (r)-n-methylnaltrexone bromide and uses thereofSMOLENSKAYA VALERIYA N·Filed 2008·Application pending·0 cites
- 1159US2016206612A1Oral formulations and lipophilic salts of methylnaltrexoneWYETH LLC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kadum A. Al Shareffi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →